Patents by Inventor Anna-Kathrine Fevre

Anna-Kathrine Fevre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized alpha-amylase variants and use of the same
    Patent number: 11248193
    Abstract: The present invention relates to alpha-amylase variants having an improved stability as compared to the parent alpha-amylase. The invention further relates to use of the variants, compositions comprising the variants, and methods of producing the variants.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: February 15, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Anna-Kathrine Fevre
  • STABILIZED ALPHA-AMYLASE VARIANTS AND USE OF THE SAME
    Publication number: 20200071638
    Abstract: The present invention relates to alpha-amylase variants having an improved stability as compared to the parent alpha-amylase. The invention further relates to use of the variants, compositions comprising the variants, and methods of producing the variants.
    Type: Application
    Filed: November 14, 2019
    Publication date: March 5, 2020
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Anna-Kathrine Fevre
  • Stabilized alpha-amylase variants and use of the same
    Patent number: 10519405
    Abstract: The present invention relates to alpha-amylase variants having an improved stability as compared to the parent alpha-amylase. The invention further relates to use of the variants, compositions comprising the variants, and methods of producing the variants.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: December 31, 2019
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Anna-Kathrine Fevre
  • STABILIZED ALPHA-AMYLASE VARIANTS AND USE OF THE SAME
    Publication number: 20170292095
    Abstract: The present invention relates to alpha-amylase variants having an improved stability as compared to the parent alpha-amylase. The invention further relates to use of the variants, compositions comprising the variants, and methods of producing the variants.
    Type: Application
    Filed: April 7, 2017
    Publication date: October 12, 2017
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Anna-Kathrine Fevre